Nephrogenic Systemic Fibrosis
Hundreds of cases of NSF have been reported in the nephrogenic fibrosing dermopathy/NSF registry that is currently maintained at the Yale University. Recent reports suggest a etiologic link between systemic administration of gadolinium-containing magnetic resonance imaging contrast agents in patients with renal insufficiency and the development of NSF.
If you need more information please call our Law Firm toll free at 1-800-862-1260.
TRADEMARK NOTICE: Magnevist, Omniscan, OptiMARK, ProHance and Multihance are trademarks of Bayer Schering Pharma, GE Healthcare, Chalfont St. Giles and Bracco Diagnostics Inc. accordingly.
The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Bayer Schering Pharma, GE Healthcare, Chalfont St. Giles and Bracco Diagnostics Inc. The use of this mark is solely for informational and product identification purposes.


